Use of Tunneled Pleural Catheters in Malignant Mesothelioma

Tremblay, Alain; Patel, Milan; Michaud, Ga tane

doi:10.1097/01.laboratory.0000188644.81416.3c

Cited by 6 publications

(6 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Recently, the use of TPCs has been described as a successful treatment for MPE [7][8][9][10][11][12][13][14][15][16]. The current authors' experience with this technique suggests that high rates of symptom control can be achieved on an outpatient basis and with minimal complications [8,11,16].…”

Section: Discussionmentioning

confidence: 82%

“…The current authors' experience with this technique suggests that high rates of symptom control can be achieved on an outpatient basis and with minimal complications [8,11,16]. There is little doubt that this technique should be considered in the management of patients with MPE and trapped lung syndrome [7] or short life expectancy and poor functional status.…”

Section: Discussionmentioning

confidence: 99%

“…However, each of these methods is associated with significant morbidity and risk of mortality, whilst the impact on quality of life and symptom control has rarely been reported with these techniques. An alternative method of palliating MPE involves the use of tunnelled pleural catheters (TPC), which are inserted on an outpatient basis and have minimal associated risks or complications [7][8][9][10][11][12][13][14][15][16]. However, critics of this procedure suggest it should only be offered to patients not considered for pleurodesis procedures [17,18].…”

mentioning

confidence: 99%

See 2 more Smart Citations

Use of tunnelled catheters for malignant pleural effusions in patients fit for pleurodesis

Tremblay¹,

Mason²,

Michaud³

2007

European Respiratory Journal

109

View full text Add to dashboard Cite

The aim of the present study was to examine the effectiveness of tunnelled pleural catheters (TPC) in patients with malignant pleural effusions who would otherwise be candidates for pleurodesis.Patients were selected from a previously reported database of 250 TPC insertions. The study group was selected based on lung re-expansion and survival as a surrogate maker of eligibility for pleurodesis procedure, as defined by survival of o90 days and lung re-expansion o80% postdrainage on a standard chest radiograph 2 weeks post TPC placement.There were 109 procedures in 97 patients that met the entry criteria. Spontaneous pleurodesis (SP) was achieved following 70% of procedures and correlated with symptom control. The mean time to SP was 90 days. There was no need for a repeat procedure in 87% of cases overall and in 92% of patients experiencing SP. There were few complications and no procedure-related deaths.Tunnelled pleural catheters are an effective way of controlling malignant pleural effusions when used as first-line treatment in patients who appear to be candidates for pleurodesis procedures.

show abstract

Section: Discussionmentioning

confidence: 82%

Section: Discussionmentioning

confidence: 99%

mentioning

confidence: 99%

See 1 more Smart Citation

Use of tunnelled catheters for malignant pleural effusions in patients fit for pleurodesis

Tremblay¹,

Mason²,

Michaud³

2007

European Respiratory Journal

109

View full text Add to dashboard Cite

show abstract

“…TPCs are associated with minimal morbidity, no reported mortality, and can be easily inserted and managed on an outpatient basis [3 , 18,[24][25][26][27]. In 1999, Putnam et al [26] reported a randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions.…”

Section: Tunneled Pleural Catheter Published Resultsmentioning

confidence: 98%

Use of tunneled pleural catheters for outpatient treatment of malignant pleural effusions

Stather

Tremblay²

2007

Current Opinion in Pulmonary Medicine

Self Cite

View full text Add to dashboard Cite

show abstract

“…In 26 patients with mesothelioma in whom 31 catheters were inserted, partial or complete dyspnea relief was achieved in 93% of catheter insertions [30]. Another group noted a spontaneous pleurodesis rate of 76% in a cohort with a substantial number of mesothelioma cases (33.6%) [31].…”

Section: Use Of Tunneled Pleural Catheter In Malignant Pleural Effusionsmentioning

confidence: 96%

The use of tunneled pleural catheters in the treatment of pleural effusions

Chee¹,

Tremblay²

2011

Current Opinion in Pulmonary Medicine

Self Cite

View full text Add to dashboard Cite

TPCs are an effective management strategy for symptomatic, recurrent, malignant pleural effusions. Their use as a first-line treatment is feasible and TPCs are particularly preferred for patients with trapped lung or those who are not considered good candidates for chemical pleurodesis because of short life-expectancy. There currently lacks sufficient evidence to recommend the use of TPCs in nonmalignant pleural diseases.

show abstract

Use of Tunneled Pleural Catheters in Malignant Mesothelioma

Cited by 6 publications

References 19 publications

Use of tunnelled catheters for malignant pleural effusions in patients fit for pleurodesis

Use of tunnelled catheters for malignant pleural effusions in patients fit for pleurodesis

Use of tunneled pleural catheters for outpatient treatment of malignant pleural effusions

The use of tunneled pleural catheters in the treatment of pleural effusions

Contact Info

Product

Resources

About